• Profile
Close

Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications

European Journal of Cancer Sep 27, 2020

Lee KA, Shaw HM, Bataille V, et al. - As the health of the gut microbiome (GM) is strongly linked with therapeutic responses to immune-checkpoint inhibitors (ICIs), researchers sought to determine the implications of diet and medication on the GM for patients receiving ICI. Based on findings from short-term clinical and observational studies identified, they emphasize avoiding antibiotics before ICI initiation, and suggest providing consideration to a temporary delay of initiation of non-urgent ICI in cases having broad spectrum antibiotics within 1 month of planned treatment initiation. Discontinuation of proton pump inhibitor use is emphasized when not clearly indicated and potential switch to a histamine H2-receptor antagonist considered. Minimization of animal meat intake and maximization of plants, aiming to consume ≥ 30 plant types weekly, should be advised to patients. The chance of ICI response is reported to improve in correlation with a high fibre intake (> 30 g/day). Given the possible beneficial impact of fermented foods on the GM, their introduction is emphasized where possible. Ideally, referral of all patients to a nutritionist or dietician with knowledge of GM before commencing ICI should be done.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay